PRKACB Antikörper (N-Term)

Produktnummer ABIN928850

Produktdetails anti-PRKACB Antikörper

Target: PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))

Bindungsspezifität: N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PRKACB Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: Purified

Immunogen: PRKACB antibody was raised in rabbit using the N terminal of PRKACB as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

PRKACB Blocking Peptide, catalog no. 33R-6047, is also available for use as a blocking control in assays to test for specificity of this PRKACB antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu PRKACB

Target: PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))

Andere Bezeichnung: PRKACB (PRKACB Produkte)

Synonyme: PKACB antikoerper, XPKAbeta antikoerper, kin-1 antikoerper, pkacb antikoerper, prkacba antikoerper, PRKACB antikoerper, prkacb antikoerper, wu:fz54b03 antikoerper, zgc:110804 antikoerper, Pkacb antikoerper, protein kinase cAMP-activated catalytic subunit beta antikoerper, protein kinase cAMP-activated catalytic subunit beta S homeolog antikoerper, protein kinase, cAMP-dependent, catalytic, beta antikoerper, protein kinase, cAMP-dependent, catalytic, beta b antikoerper, protein kinase, cAMP dependent, catalytic, beta antikoerper, PRKACB antikoerper, prkacb.S antikoerper, prkacb antikoerper, Prkacb antikoerper, prkacbb antikoerper

Hintergrund: CAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Synonyms: Polyclonal PRKACB antibody, Anti-PRKACB antibody, protein kinase, cAMP-dependent, catalytic, beta antibody, DKFZp781I2452 antibody, MGC41879 antibody, MGC9320 antibody, PKACB antibody.

Pathways: AMPK Signaling, Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Lipid Metabolism